INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (53)
2024
-
Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial
JAMA Neurology, Vol. 81, Núm. 4, pp. 327-335
-
Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles
JAMA, Vol. 331, Núm. 9, pp. 750-763
-
Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial
The Lancet, Vol. 403, Núm. 10428, pp. 731-740
-
Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial
International Journal of Stroke, Vol. 19, Núm. 1, pp. 120-126
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Association of Endovascular Thrombectomy vs Medical Management with Functional and Safety Outcomes in Patients Treated beyond 24 Hours of Last Known Well: The SELECT Late Study
JAMA Neurology, Vol. 80, Núm. 2, pp. 172-182
-
Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy
Frontiers in Aging Neuroscience, Vol. 15
-
Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey
Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 439-445
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
International controlled study of revascularization and outcomes following COVID-positive mechanical thrombectomy
European Journal of Neurology, Vol. 29, Núm. 11, pp. 3273-3287
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
-
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance
Neurologia, Vol. 37, Núm. 2, pp. 136-150
-
Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort
Annals of Neurology, Vol. 92, Núm. 3, pp. 364-378
2021
-
Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry
International Journal of Stroke, Vol. 16, Núm. 4, pp. 437-447
-
Circulating AQP4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-15
-
Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer’s disease
Biomedicines, Vol. 9, Núm. 1, pp. 1-14